Vanda Lux
Impact in
Papers in
-
- RNA and protein synthesis mechanisms 4
- Ubiquitin and proteasome pathways 3
- Genomics and Chromatin Dynamics 2
- RNA modifications and cancer 2
- Virology 5
- HIV Research and Treatment 5
- Co-authors
- Michael Ehrmann (5 shared papers)Hans‐Georg Kräusslich (4 shared papers)Sven Fengler (1 shared paper)Conrad C. Weihl (1 shared paper)Monika Bug (1 shared paper)Hemmo Meyer (1 shared paper)Chrisovalantis Papadopoulos (1 shared paper)Philipp Kirchner (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)European Journal of Medicinal Chemistry (1 paper)The EMBO Journal (1 paper)Cells (1 paper)Science (1 paper)
- Partner nations
- GermanyCzechiaUnited Kingdom
In The Last Decade
Vanda Lux
15 papers receiving 731 citations
Peers
Comparison fields: 5 of 79
- Virology 118
- Neurology 142
- Physiology 39
- Structural Biology 11
- Cell Biology 122
Countries citing papers authored by Vanda Lux
This map shows the geographic impact of Vanda Lux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanda Lux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanda Lux more than expected).
Fields of papers citing papers by Vanda Lux
This network shows the impact of papers produced by Vanda Lux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanda Lux. The network helps show where Vanda Lux may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanda Lux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 255 | |
| 2 | 2014 | 108 | |
| 3 | 2014 | 87 | |
| 4 | 2012 | 58 | |
| 5 | 2010 | 50 | |
| 6 | 2021 | 42 | |
| 7 | 2015 | 42 | |
| 8 | 2012 | 39 | |
| 9 | 2016 | 21 | |
| 10 | 2023 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2024 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2024 | 3 | |
| 15 | 2025 | 2 |
About Vanda Lux
Vanda Lux is a scholar working on Molecular Biology, Virology, Neurology, Epidemiology and Infectious Diseases, having authored 15 papers that have together received 735 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), RNA and protein synthesis mechanisms (4 papers), Cerebrovascular and genetic disorders (3 papers), Ubiquitin and proteasome pathways (3 papers), Genomics and Chromatin Dynamics (2 papers), Cytomegalovirus and herpesvirus research (2 papers), RNA modifications and cancer (2 papers) and Spine and Intervertebral Disc Pathology (1 paper). The work is most often cited by research in Virology (118 citations), Neurology (142 citations), Physiology (39 citations), Structural Biology (11 citations) and Cell Biology (122 citations). Vanda Lux has collaborated with scholars based in Germany, Czechia and United Kingdom. Frequent co-authors include Michael Ehrmann, Hans‐Georg Kräusslich, Sven Fengler, Conrad C. Weihl, Monika Bug, Hemmo Meyer, Chrisovalantis Papadopoulos, Philipp Kirchner, Khalid Arhzaouy and Nina Schulze. Their work appears in journals such as Proceedings of the National Academy of Sciences, European Journal of Medicinal Chemistry, The EMBO Journal, Cells and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.